Eyes Openers
  • World News
  • Business
  • Stocks
  • Politics
  • World News
  • Business
  • Stocks
  • Politics

Eyes Openers

Stocks

Weekend Daily: The Biotech Sector Should Come Back First

by admin September 26, 2022
September 26, 2022
Weekend Daily: The Biotech Sector Should Come Back First

The market has turned for the worst in recent weeks and continues to fall in a bear market fashion.

Most of our portfolio strategies are holding more than 50% cash, some are utilizing inverse ETFs, and in my discretionary trading service, we are largely in cash. We are looking for profitable opportunities to deploy dry powder.

One of the areas we are watching is the biotech sector, represented above by the iShares Biotech ETF (IBB) or AKA “Big Brother.” The biotech industry is often considered risky, since biotech companies, especially in the small/micro-cap sector, are often speculative, and individual stocks can suffer vicious losses. Yet many areas of biotech show incredible promise, including regenerative medicine, gene therapy, genomics, new advances in treating cancer and autoimmune disorders, to name just a few. 

IBB should be on your shopping list for a few reasons:

1. (IBB) “Big Brother” is one of our Modern Family members and is trading well above the June lows while the indices tested them on Friday — we call that relative strength.

2. Biotech received a $2 billion boost from the US government earlier this week.

One of the goals is cutting cancer deaths in half in the next 25 years.The outcome of this government biotech initiative is unknown, but can only be seen as a positive for the industry.

3. IBB is sitting at an interesting pivotal support level.

IBB closed Friday over 115.Next key level to clear and give us a good risk point for entry is 118.

We are monitoring the biotech sector for a near-term rebound because of rising worldwide demand for medical advancements, aging populations and new government backing for research. 

For more information on how to invest profitably in sectors like biotech, please reach out to Rob Quinn, our Chief Strategy Consultant, by clicking here.

Mish’s Upcoming Seminars

ChartCon 2022: October 7-8th, Seattle (FULLY VIRTUAL EVENT). Join me and 16 other elite market experts for live trading rooms, fireside chats, and panel discussions. Learn more here.

The Money Show: Join me and many wonderful speakers at the Money Show in Orlando, beginning October 30th running thru November 1st; spend Halloween with us!

Get your copy of Plant Your Money Tree: A Guide to Growing Your Wealth and a special bonus here.

Follow Mish on Twitter @marketminute for stock picks and more. Follow Mish on Instagram (mishschneider) for daily morning videos. To see updated media clips, click here.

Mish in the Media

A business cycle is about 6-7 years – where are the indices now and what should you watch for? Mish discusses this question in this appearance on Fox’s Making Money with Charles Payne.

Mish discusses how the Fed needed to be more aggressive, as they now have more to raise this year, with a panel on Coindesk.

See Mish’s latest article for CMC Markets, titled “Our Go-To Trade Indicator Post-Fed Meeting“.

Mish discusses price, momentum and market psychology in this appearance on Business First AM.

ETF Summary

S&P 500 (SPY): At least held June lows, for what’s it worth. 362 support, 371 resistance.Russell 2000 (IWM): Held June lows; 163 support, 170 resistance 170.Dow (DIA): Broke June lows-harbinger? 292 support, 300 resistance.Nasdaq (QQQ): Held June lows; 269 support, 280 resistance.KRE (Regional Banks): Relative outperformer holding the 6-month calendar range high; 60 pivotal.SMH (Semiconductors): Held the 6-month calendar range low, making 191 pivotal.IYT (Transportation): Transports unhappy, unless Friday’s gap turns out an island bottom.IBB (Biotechnology): 112 support, 118 resistance.XRT (Retail): Held the 6-month calendar range low; 55 support, 60 resistance.

Mish Schneider

MarketGauge.com

Director of Trading Research and Education

previous post
Let Your Risk Tolerance Determine If You Buy the Dip
next post
The Perfect Starter to Build Your Daily Market Review Routine

Related Posts

Exceptionally Bearish Breadth

September 26, 2022

My Sustainability Ratios Remain Fairly Strong And Suggest...

October 23, 2022

This Semiconductor ETF is Hitting a Critical Juncture

March 3, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular Posts

    • 1

      Head of Republican Party mocks speaking abilities of Fetterman, Biden

      October 28, 2022
    • 2

      Biden’s unwarranted bragging about reducing the budget deficit

      September 26, 2022
    • 3

      Russian TV is very excited about Такер Карлсон’s Nord Stream theory

      September 30, 2022
    • 4

      Strong Sector Rotation To Financials, but will it be enough to turn the market back up?

      October 14, 2022
    • 5

      Mish’s Daily: Mid-September Column Highlights

      September 29, 2022

    Categories

    • Business (1,481)
    • Politics (1,721)
    • Stocks (630)
    • World News (1,134)
    • About Us
    • Contacts
    • Terms & Conditions
    • Privacy Policy
    • Email Whitelisting

    Disclaimer: EyesOpeners.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2023 EyesOpeners.com | All Rights Reserved